CLASS II Drug recall · Reported 24 Jan 2018 · FDA Enforcement Report

Shiseido Future Solution LX Discovery Set contains SPF 50+ recalled

Shiseido America is recalling Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 9%, octocrylebe 0%, distributed nationwide in the US. The recall was initiated on 14 Dec 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSKU#: 95167
Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0216-2018
FDA event ID
78791
Recalling firm
Shiseido America, East Windsor, NJ
Classification
Class II
Status
Terminated
Recall initiated
14 Dec 2017
FDA classified
12 Jan 2018
Reported
24 Jan 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

14 Dec 2017Recall initiated by company
12 Jan 2018Classified by FDA+29 days
24 Jan 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022,

Where it was distributed

Product was distributed nationwide.

Nationwide

Questions about this recall

Is Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 9%, octocrylebe 0% recalled?

Yes. Shiseido America recalled Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 9%, octocrylebe 0% on 14 Dec 2017. The recall is Class II and its status is Terminated. Recall number D-0216-2018.

Why was it recalled?

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Which lots are affected?

SKU#: 95167

Where was it sold?

Product was distributed nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Shiseido America

All 5

Other Shiseido future recalls

All 4